Predicting factor analysis of gastrointestinal bleeding complication among hospitalised ischemic stroke patients
DOI:
https://doi.org/10.46542/pe.2023.232.139143Keywords:
Antiplatelet, Gastrointestinal bleeding, Ischemic stroke, Predicting factorAbstract
Background: Stroke is a common cardiovascular disease and the biggest cause of death and disability in the world. Treatment in affected patients aims to stabilise their condition and prevent further deterioration. One of the therapies in stroke patients is the administration of antiplatelet which may also cause adverse reactions in the form of gastrointestinal bleeding.
Objectives: This study aims to analyse the factors that can predict the emergence of gastrointestinal bleeding in hospitalised Ischemic stroke patients.
Methods: A cohort study was conducted within a population of hospitalised patients diagnosed with Ischemic stroke. Patients' data from the hospital stroke registry was analysed. The significance of factors that can predict gastrointestinal bleeding incidence and the main predictor was determined.
Results: The results showed that out of the 96 patients included, 49 experienced gastrointestinal bleeding. Factors that had significant relationships with the incidence of gastrointestinal bleeding were symptoms of decreased consciousness with OR 9.03; 95% CI: 3.361 – 24.22, and loading dose OR 5.769; 95% CI: 1.191 – 27.941. In addition, the main predicting factor was symptoms of decreased consciousness with a p < 0.05 (<0.010), and OR value of 2.165 with 95% CI: 3.177 – 23.906.
Conclusion: The occurrence of decreased consciousness can be a predictor of gastrointestinal bleeding.
References
AHA. (2021). 2021 Heart Disease & Stroke Statistical Update Fact Sheet Global Burden of Disease. Circulation https://doi.org/10.1161/CIR.0000000000000950
Allen, C.L. & Bayraktutan, U. (2008). Risk factor for Ischaemic stroke. International Journal of Stroke, 3:105-116
Boehme, A.K., Esenwa, C. & Elkind, M.S. (2017). Stroke Risk Factors, Genetics, and Prevention. Circ Res, 120(3):472-495 https://doi.org/10.1161/CIRCRESAHA.116.308398
Chisholm-Burns, M.A., Schwinghammer, T.L., Wells, B.G., Malone, P.M., Kolesar, J.M. & DiPiro, J.T. (2016). Pharmacotherapy Principles & Practice, 4th Edition (4th ed.). McGraw-Hill Companies, Inc
Du, W., Zhao, X., Wang, Y., Pan, Y., Liu, G., Wang, A., Ji, R., Liu, L., Gu, H., Dong, K., Wang, P., Wang, Y. & China National Stroke Registry, i. (2020).Gastrointestinal bleeding during acute ischaemic stroke hospitalisation increases the risk of stroke recurrence. Stroke Vasc Neurol, 5(2):116-120 https://doi.org/10.1136/svn-2019-000314
Fekadu, G., Chelkeba, L., Melaku, T., Gamachu, B., Gebre, M., Bekele, F. & Fetensa, G. (2019). Management protocols and encountered complications among stroke patients admitted to the stroke unit of Jimma university medical centre, Southwest Ethiopia: Prospective observational study. Ann Med Surg (Lond), 48:135-143 https://doi.org/10.1016/j.amsu.2019.11.003
Fu, J. (2019). Factors affecting the occurrence of gastrointestinal bleeding in acute ischemic stroke patients. Medicine (Baltimore), 98(28):e16312 https://doi.org/10.1097/MD.0000000000016312
Hackam, D.G. & Spence, J.D. (2019). Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack. Stroke, 50(3):773-778 https://doi.org/10.1161/strokeaha.118.023954
Johnston, S.C., Easton, J.D., Farrant, M., Barsan, W., Conwit, R.A., Elm, J.J., Kim, A.S., Lindblad, A.S., Palesch, Y.Y., Clinical Research Collaboration, N.E.T.T.N. & the, P. I. (2018). Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med, 379(3):215-225 https://doi.org/10.1056/NEJMoa1800410
Kemenkes,RI. (2019). Infodatin, Stroke : Don't be The One
Lanas, A. & Gargallo, C.J. (2015). Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol, 50(6):626-637 https://doi.org/10.1007/s00535-015-1038-3
Ogata, T., Kamouchi, M., Matsuo, R., Hata, J., Kuroda, J., Ago, T., Sugimori, H., Inoue, T., Kitazono, T. & Fukuoka Stroke, R. (2014). Gastrointestinal bleeding in acute ischemic stroke: recent trends from the Fukuoka stroke registry. Cerebrovasc Dis Extra, 4(2):156-164 https://doi.org/10.1159/000365245
Parmar, P. (2018). Stroke: Classification and Diagnosis. Pharmaceutical Journal, 15:1-16 https://doi.org/10.1211/cp.2018.20204150
Powers, W. J., Rabinstein, A.A., Ackerson, T., Adeoye, O.M., Bambakidis, N.C., Becker, K., Biller, J., Brown, M., Demaerschalk, B.M., Hoh, B., Jauch, E.C., Kidwell, C.S., Leslie-Mazwi, T.M., Ovbiagele, B., Scott, P.A., Sheth, K.N., Southerland, A.M., Summers, D.V. & Tirschwell, D.L. (2019). Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 50(12):e344-e418 https://doi.org/10.1161/STR.0000000000000211
Sandercock, P.A., Counsell, C., Tseng, M.C. & Cecconi, E. (2014). Oral antiplatelet therapy for acute Ischaemic stroke. Cochrane Database Syst Rev(3):CD000029 https://doi.org/10.1002/14651858.CD000029.
Vallurupalli, N.G. & Goldhaber, S.Z. (2006). Gastrointestinal complications of dual antiplatelet therapy. Circulation, 113(12):e655-658 https://doi.org/10.1161/CIRCULATIONAHA.105.590612
Venketasubramanian, N., Yoon, B.W., Pandian, J. & Navarro, J.C. (2017). Stroke Epidemiology in South, East, and South-East Asia: A Review. J Stroke, 19(3):286-294 https://doi.org/10.5853/jos.2017.00234
